{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T12:58:43Z","timestamp":1786366723461,"version":"build-2736575974"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T00:00:00Z","timestamp":1695254400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.jpainsymman.2023.09.018","type":"journal-article","created":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T21:03:10Z","timestamp":1695416590000},"page":"50-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Patient Controlled Subcutaneous Analgesia of Hydromorphone Versus Morphine to Treat Moderate and Severe Cancer Pain: A Randomized Double-Blind Controlled Trial"],"prefix":"10.1016","volume":"67","author":[{"given":"Xianzheng","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maotong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpainsymman.2023.09.018_bib0001","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/annonc\/mdm056","article-title":"Prevalence of pain in patients with cancer: a systematic review of the past 40 years","volume":"18","author":"van den Beuken-van Everdingen","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jpainsymman.2023.09.018_bib0002","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/papr.12422","article-title":"Current status of malignant neuropathic pain in Chinese patients with cancer: report of a hospital-based investigation of prevalence, etiology, assessment, and treatment","volume":"17","author":"Lu","year":"2017","journal-title":"Pain Pract"},{"key":"10.1016\/j.jpainsymman.2023.09.018_bib0003","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S1470-2045(09)70200-1","article-title":"Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials","volume":"10","author":"Quinten","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jpainsymman.2023.09.018_bib0004","series-title":"WHO guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents","year":"2018"},{"issue":"Suppl 4","key":"10.1016\/j.jpainsymman.2023.09.018_bib0005","doi-asserted-by":"crossref","first-page":"iv166","DOI":"10.1093\/annonc\/mdy152","article-title":"Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines","volume":"29","author":"Fallon","year":"2018","journal-title":"Ann Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.jpainsymman.2023.09.018_bib0006","first-page":"11","article-title":"Breakthrough cancer pain and rational drug use","volume":"25","author":"Olarte","year":"2017","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jpainsymman.2023.09.018_bib0007","doi-asserted-by":"crossref","first-page":"4567192","DOI":"10.1155\/2022\/4567192","article-title":"Serious adverse events after a single shot of intrathecal morphine: a case series and systematic review","volume":"2022","author":"Koning","year":"2022","journal-title":"Pain Res Manag"},{"key":"10.1016\/j.jpainsymman.2023.09.018_bib0008","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1136\/archdischild-2020-319059","article-title":"Morphine or hydromorphone: which should be preferred? A systematic review","volume":"106","author":"Sp\u00e9nard","year":"2021","journal-title":"Arch Dis Child"},{"issue":"5 Suppl","key":"10.1016\/j.jpainsymman.2023.09.018_bib0009","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/j.jpainsymman.2005.01.007","article-title":"Hydromorphone","volume":"29","author":"Murray","year":"2005","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2023.09.018_bib0010","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/bja\/aer232","article-title":"Comparative clinical effects of hydromorphone and morphine: a meta-analysis","volume":"107","author":"Felden","year":"2011","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jpainsymman.2023.09.018_bib0011","article-title":"Hydromorphone for cancer pain","volume":"8","author":"Li","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jpainsymman.2023.09.018_bib0012","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1097\/j.pain.0000000000001957","article-title":"Intrathecal delivery of hydromorphone vs morphine for refractory cancer pain: a multicenter, randomized, single-blind, controlled noninferiority trial","volume":"161","author":"Ma","year":"2020","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2023.09.018_bib0013","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.6004\/jnccn.2020.7699","article-title":"Comparing patient-controlled analgesia versus non-PCA hydromorphone titration for severe cancer pain: a randomized phase III trial","volume":"19","author":"Lin","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.jpainsymman.2023.09.018_bib0014","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0885-3924(99)00036-6","article-title":"Continuous subcutaneous infusion of morphine vs. hydromorphone: a controlled trial","volume":"18","author":"Miller","year":"1999","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2023.09.018_bib0015","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1177\/1049909120912954","article-title":"Pharmacy-led quality improvement project on pain control using continuous subcutaneous infusion of opioids in an inpatient hospice unit","volume":"37","author":"Romero","year":"2020","journal-title":"Am J Hosp Palliat Care"},{"key":"10.1016\/j.jpainsymman.2023.09.018_bib0016","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1016\/S1470-2045(12)70040-2","article-title":"Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC","volume":"13","author":"Caraceni","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jpainsymman.2023.09.018_bib0017","doi-asserted-by":"crossref","first-page":"977","DOI":"10.6004\/jnccn.2019.0038","article-title":"Adult cancer pain, version 3.2019, NCCN Clinical Practice Guidelines in Oncology","volume":"17","author":"Swarm","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.jpainsymman.2023.09.018_bib0018","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1472-684X-7-17","article-title":"A randomized, double-blind comparison of OROS(R) hydromorphone and controlled-release morphine for the control of chronic cancer pain","volume":"7","author":"Hanna","year":"2008","journal-title":"BMC palliative care"},{"key":"10.1016\/j.jpainsymman.2023.09.018_bib0020","doi-asserted-by":"crossref","first-page":"5345","DOI":"10.1002\/cam4.3194","article-title":"Patient-controlled subcutaneous analgesia using sufentainil or morphine in home care treatment in patients with stage III-IV cancer: a multi-center randomized controlled clinical trial","volume":"9","author":"Wan","year":"2020","journal-title":"Cancer Med"},{"key":"10.1016\/j.jpainsymman.2023.09.018_bib0021","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.pain.2013.09.005","article-title":"Pain and the onset of depressive and anxiety disorders","volume":"155","author":"Gerrits","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2023.09.018_bib0022","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1017\/S1478951513001119","article-title":"Assessment of sleep disturbance in lung cancer patients: relationship between sleep disturbance and pain, fatigue, quality of life, and psychological distress","volume":"13","author":"Nishiura","year":"2015","journal-title":"Palliat Support Care"},{"key":"10.1016\/j.jpainsymman.2023.09.018_bib0023","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1200\/PO.20.00158","article-title":"Breakthrough cancer pain clinical features and differential opioids response: a machine learning approach in patients with cancer from the IOPS-MS study","volume":"4","author":"Pantano","year":"2020","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.jpainsymman.2023.09.018_bib0024","doi-asserted-by":"crossref","first-page":"893530","DOI":"10.3389\/fpain.2022.893530","article-title":"Rapid-onset opioids for management of breakthrough cancer pain: considerations for daily practice","volume":"3","author":"Bossi","year":"2022","journal-title":"Front Pain Res (Lausanne)"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392423006899?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392423006899?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:41:34Z","timestamp":1760132494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0885392423006899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0885392423006899"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2023.09.018","relation":{},"ISSN":["0885-3924"],"issn-type":[{"value":"0885-3924","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient Controlled Subcutaneous Analgesia of Hydromorphone Versus Morphine to Treat Moderate and Severe Cancer Pain: A Randomized Double-Blind Controlled Trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2023.09.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc. on behalf of American Academy of Hospice and Palliative Medicine.","name":"copyright","label":"Copyright"}]}}